Catherine Geh

Catherine Geh is a Senior Cell Scientist at Peak Proteins Ltd. since April 2017, focusing on the expression and delivery of recombinant proteins for assay development and X-ray structure determination. Prior experience at AstraZeneca spans from 1997 to Present, where Catherine has held multiple senior scientist roles. As a Senior Scientist in Oncology Translational Science, responsibilities included establishing digital PCR capability to support patient selection in drug development and delivering exploratory data on ESR1 mutations from clinical trial samples. Previous roles at AstraZeneca involved the development of high-quality cellular screening assays for early-phase projects and driving key drug progression in clinical trials. Catherine Geh holds a B.Sc. (Honours) in Biochemistry with German from The University of Manchester, awarded in 1997.